MX9700170A - Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite. - Google Patents

Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite.

Info

Publication number
MX9700170A
MX9700170A MX9700170A MX9700170A MX9700170A MX 9700170 A MX9700170 A MX 9700170A MX 9700170 A MX9700170 A MX 9700170A MX 9700170 A MX9700170 A MX 9700170A MX 9700170 A MX9700170 A MX 9700170A
Authority
MX
Mexico
Prior art keywords
oil
emulsion vaccines
avian embryos
ovo immunization
ovo
Prior art date
Application number
MX9700170A
Other languages
English (en)
Inventor
Harry D Stone
Original Assignee
Los Estados Unidos De America
Por El Secretario Del Departam
Agricultura De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Los Estados Unidos De America, Por El Secretario Del Departam, Agricultura De filed Critical Los Estados Unidos De America
Publication of MX9700170A publication Critical patent/MX9700170A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Enfermedades de ave, particularmente aquellas que ponen en riesgo a las aves al inicio de su vida, son controladas por vacunacion embrional utilizando vacunas de emulsion en aceite, el sitio de inoculacion es el extremo de la albumina del huevo por medio de la entrada a través del extremo de la celda de aire del huevo.
MX9700170A 1994-06-20 1995-06-20 Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite. MX9700170A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26932594A 1994-06-20 1994-06-20
PCT/US1995/007818 WO1995035121A1 (en) 1994-06-20 1995-06-20 In ovo immunization of avian embryos with oil-emulsion vaccines

Publications (1)

Publication Number Publication Date
MX9700170A true MX9700170A (es) 1997-04-30

Family

ID=23026769

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700170A MX9700170A (es) 1994-06-20 1995-06-20 Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite.

Country Status (6)

Country Link
US (1) US5750101A (es)
EP (1) EP0772453A1 (es)
AU (1) AU2945895A (es)
CA (1) CA2192994A1 (es)
MX (1) MX9700170A (es)
WO (1) WO1995035121A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048535A (en) * 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US20040023358A1 (en) * 2001-12-21 2004-02-05 Wyeth Avian embryo particulate biomass for the production of virus antigens
US7029681B2 (en) 2002-03-08 2006-04-18 Schweitzer Chemical Corporation Multiple and multivalent DNA vaccines in ovo
US7037506B2 (en) * 2002-03-08 2006-05-02 Schweltzer Chemical Corporation Ltd. Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
CA2623867C (en) * 2005-10-13 2015-03-17 Kirin Pharma Kabushiki Kaisha Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures
CA2647939A1 (en) * 2006-03-30 2007-11-08 Embrex, Inc. Methods and compositions for vaccination of poultry
CA2725435C (en) 2009-12-15 2023-01-03 University Of Saskatchewan Vaccines for inclusion body hepatitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851006A (en) * 1955-11-03 1958-09-09 Swift & Co Hatching of eggs
US4040388A (en) * 1976-02-27 1977-08-09 Agrimatic Corporation Method and apparatus for automatic egg injection
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US5106617A (en) * 1989-06-27 1992-04-21 Embrex, Inc. Method of treating immature birds with IL-2
US5206015A (en) * 1989-06-05 1993-04-27 The United States Of America As Represented By The Secretary Of Agriculture Introduction of bacteria in ovo
US5136979A (en) * 1991-09-25 1992-08-11 Embrex, Inc. Modular injection system for avian embryos

Also Published As

Publication number Publication date
US5750101A (en) 1998-05-12
AU2945895A (en) 1996-01-15
EP0772453A1 (en) 1997-05-14
WO1995035121A1 (en) 1995-12-28
CA2192994A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
de Steven The influence of age on the breeding biology of the Tree Swallow Iridoprocne bicolor
Wilson A chemical releaser of alarm and digging behavior in the ant Pogonomyrmex badius (Latreille)
ATE255419T1 (de) Für den vogelembryo geeignete multivalente impfstoffe
NO20010922D0 (no) FremgangsmÕte for DNA vaksinering
RU2010136627A (ru) Способы и композиции для вакцинации домашней птицы
US4795635A (en) Vaccine system
MX9700170A (es) Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite.
ATE211922T1 (de) Attenuiertes lebendvakzin zur verwendung in eiern
BR0306941A (pt) Método para identificar se um ovo contém um embrião vivo, e, método e aparelho para produzir uma vacina dentro de uma pluralidade de ovos
DK0994721T3 (da) Nervevækstfaktor som vaccineadjuvans
RU2005133621A (ru) Способы продуцирования гамет у птиц
HK1087949A1 (en) Immunogene adherence and method of making and using the same
DE602004012531D1 (de) Verarmung an endogenen primordialen keimzellen in vogelspezies
US4928629A (en) Egg inoculation method
Breitenbach et al. Pituitary prolactin levels in laying, incubating and brooding pheasants (Phasianus colchicus).
Farner et al. The temporal relationship between the cycle of testicular development and molt in the white-crowned sparrow, Zonotrichia leucophrys gambelii
CA1326818C (en) Disease control in avian species by embryonal vaccination with a nonreplicating immunogen
DK16087A (da) Mastitis-vaccine
Hirata et al. Studies on immunologic depression in chickens
Mitchell et al. Further experiments relating to the propagation of virus in the bovine mammary gland
WO2017081232A1 (en) Inactivated avian reovirus vaccine for use in a method to increase the hatchability of poultry eggs
Bier et al. Anisakis simplex (nematoda ascaridoidea): formation of immunogenic attachment caps in pigs
Siopes et al. The effect of light intensity on turkey poult eye morphology
Reynolds Method to provide artificial passive immunity in birds
Abbott et al. Embryonic Development of the Cockatiel (Nymphicus hollandicus)